Jun 24 |
Sarepta Therapeutics (SRPT) Soars 30.1%: Is Further Upside Left in the Stock?
|
May 30 |
Russell 3000: Inovio, Ocugen among healthcare additions; Assertio, Ginkgo Bioworks among deletions
|
May 29 |
We Think Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) CEO Compensation Package Needs To Be Put Under A Microscope
|
May 12 |
US$3.50 - That's What Analysts Think Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Is Worth After These Results
|
May 12 |
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript
|
May 11 |
Sangamo Therapeutics First Quarter 2024 Earnings: US$0.27 loss per share (vs US$0.13 profit in 1Q 2023)
|
May 10 |
Sangamo Therapeutics Reports Q1 2024 Results: A Deep Dive into Financials and Strategic Highlights
|
May 9 |
Sangamo Therapeutics, Inc. (SGMO) Q1 2024 Earnings Call Transcript
|
May 9 |
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates
|
May 9 |
Sangamo Therapeutics GAAP EPS of -$0.27 misses by $0.05, revenue of $0.48M misses by $5.88M
|